RADITIONAL pharmacotherapy for the central nervous system is made difficult by the presence of the BBB, which prevents most drugs that are hydrophilic or of moderate molecular weight from diffusing into the interstitial space of the brain. Convection-enhanced delivery of drugs via positive pressure infusion is evolving as a technique for site-specific drug delivery that bypasses the BBB. 1, 4, 12, 17, 27 Protocols for CED are designed to deliver clinically useful volumes of therapeutic agents into a specific region of the brain in which adequate concentrations of the drug cannot otherwise be established via systemic delivery. There is extensive literature on the delivery of solutions of macromolecules by using this technique for the purposes of characterizing the distribution pattern and confirming the safety of the method (see the review by Broaddus, et al., 2 for citations to many relevant papers).
rounds of in vivo testing in rodent and large animal models are needed to identify and resolve the various technical and clinical issues that arise in advance of human clinical trials. In the case of CED, however, there are some limitations to the utility of extensive in vivo testing. For instance, most of the best-known animal brain models have smaller volumes than the human brain (for example, the human/rat volume ratio is ~1000:1), and thus it is difficult to use these models to mimic infusion protocols that can lead to clinically relevant volumes of distribution. Moreover, it is not possible to visualize and monitor the real-time volume of distribution during infusions into an animal brain unless MR imaging is available and can be used. These difficulties plus the expense associated with in vivo testing have prompted us to consider in vitro alternatives to living brain for many preliminary studies in which such an approach could be workable.
The question becomes one of finding a simple, realistic, robust, and inexpensive brain phantom material that is optimal for use in infusion studies. Although various efforts have been aimed at demonstrating that the diffusion of macromolecules through porous gels has important implications for understanding how such species are transported in living tissue, 21, 23 there has been as yet no validated brain tissue phantom engineered specifically for use in CED studies. In this work, we present data that show how low-concentration agarose gels can mimic the features of brain tissue critical to infusion studies and thus serve as an appropriate type of brain surrogate for preclinical CED investigations such as catheter testing and the evaluation of physical predictions of this type of porous media flow. We compare the gel-based results with those obtained from equivalent CED studies that were conducted in an animal model to confirm that the volumes of distribution, the pressure profiles, and the catheter insertion forces found in both cases were indeed similar.
Materials and Methods

Agarose Gel Preparation
Agarose gels were prepared by mixing agarose powder and 1 ϫ TBE (89 mM Tris; 89 mM boric acid; 2 mM ethylenediaminetetraacetic acid; and pH 8.4). The mixture was heated until all the powder had dissolved and was then boiled for 5 minutes. When the resulting solution had cooled to nearly 50˚C, approximately 500 ml was poured into a rectangular container made of thin-walled transparent Plexiglas with dimensions of 10 ϫ 10 ϫ 7 cm to simulate a large fraction of the volume of the human brain. A disposable MR imaging-compatible trajectory guide (Navigus; Image-Guided Neurologics, Inc., Melbourne, FL) was mounted in the rectangular lid of the container and served as the insertion and guidance path for the catheter used to deliver the infusate into the gel. The agarose gel solidified as it cooled to room temperature.
Animal Preparation
Six Yorkshire pigs each weighing 6 to 9 kg were used. The pigs had free access to water but were not fed for 12 hours before the experiment. The pigs were initially sedated by an intramuscular injection of a mixture of ketamine (25 mg/kg) and xylazine (2 mg/ kg). After an intravenous injection of pentothal (10-25 mg/kg), each pig was intubated and given artificial ventilation with 1% isoflurane in a 70% nitrous oxide/30% oxygen mixture to maintain anesthesia throughout the experiment. Sterile instruments and aseptic techniques were used in all surgical procedures. A neck incision was made to access the external jugular vein and carotid artery, and both vessels were cannulated for fluid complement and blood pressure monitoring. The anesthetized animal was placed on a surgical table and the scalp in the midline was incised. A burr hole was then placed in the skull 1 cm lateral to the midline at the bregma. A disposable MR imaging-compatible trajectory guide (Navigus; Image-Guided Neurologics, Inc.) for the infusion catheter was installed at the burr hole and secured to the skull by applying titanium screws. The wound was then closed by surgical suture.
Infusion and Pressure Measurement
A single end-port microcatheter (one of four from the ARRAY system; Image-Guided Neurologics, Inc.) was filled with a 1:100 dilution of Omniscan (gadodiamide final concentration 5 mM, MW 573; Nycomed, Inc., Princeton, NJ). It was subsequently inserted through the trajectory guide to a depth of 2.5 cm in the gel or brain. The gel box or pig was placed in the bore of the MR imager. The infusate was delivered at the rate of 0.5 l per minute for the first 60 minutes and 1 l per minute for the second 60 minutes by a motorized syringe (Bioanalytical Systems; West Lafayette, IN). The volume of distribution was observed using MR imaging for 60 minutes after cessation of the infusion. A T-junction was used to connect a pressure sensor to the infusion catheter to monitor the line pressure during the infusion process. The pressure (model BP-1; World Precision Instruments, Inc., Sarasota, FL) had a sensitivity of approximately 0.01 mm Hg. The pressure data were recorded through a PCbased model DUO 18 two-channel, 18-bit data acquisition system (World Precision Instruments, Inc.) and later imported into a software program (SigmaPlot; Jandel, San Rafael, CA) for statistical analysis. Pressure measurements were acquired by the PC capture system at a rate of five data points per second. The data were then averaged to obtain a single value for each 5-minute interval. The resulting values for the 5-minute epochs were subsequently averaged for all infusions performed under the same conditions with each different gel or animal. The SDs of these values were then calculated and displayed graphically.
Imaging and Image Processing
Experiments involving MR imaging were performed using a 2.4-tesla, 40-cm bore magnet (Bruker Medical, Inc., Billerica, MA) with a 24-cm open-bore actively shielded gradient set (maximum gradient strength 5 G/cm). For transmission and reception, a 20-cm inner-diameter "birdcage design" radiofrequency coil was used. The animals were mounted in a specially designed stereotactic device that allowed for rigid ("sphinx positioning") support of the head. Body temperature was maintained using a hot water blanket. Magnetic resonance imaging was performed using a standard T 1 -weighted spin-echo protocol (TR 700 msec, TE 10 msec). The matrix size was 128 ϫ 128 over an 8-cm field of view. Images were acquired during a 5-minute cycle over the time course of the experiment.
Magnetic resonance images of brain sections were transferred from the imager to a laboratory computer and the volumes of distribution of the Gd infusate were then measured and analyzed using SigmaScan (Systat Software, Inc., Point Richmond, CA) software. This system was used to calculate the area of distribution of Gd in each brain section and the section thickness (3 mm) was then used to calculate the volume per slice. The sum of these values was taken as the volume of distribution of the Gd. In some cases, infusions of gadodiamide into gel samples were also imaged using the same MR imaging system. In other cases, BPB dye (MW 690) was used as the infusate and a videomicroscopy system (ϫ 40) was used to monitor the volumes of distribution of the dye as a function of time. 7 
Measurement of the Penetration Transients and the Catheter Insertion and Drag Forces
Force measurement experiments were conducted by mechanically advancing probes into the agarose gels and pig brains. The probe used in the experiments was a standard 3-mm ventricular catheter, stiffened by an internal stylet. The stylet was mounted on the sensor shaft of a precision force gauge (model DGGS-R-250-g; Chatillon, Largo, FL), and the entire assembly could be driven either forward or backward at a constant speed by an electrical motor. This was the same apparatus used by Howard, et al., 14 to measure penetration forces and tissue drag forces acting on catheters moving through in vivo human brain tissue. In preparation for use, a small burr hole was made in the skull and the dura mater was opened at the intended penetration site for the animal study. For the gel study, the probe was placed above the surface of the gel at the same distance used in the brain. The probes were advanced at a rate of 0.33 mm per second and inserted into the tissue or gel to depths ranging from 2 to 3.5 cm. During each run, the data from the force measurements were acquired at a rate of four samples per second and stored by the computer for off-line analysis.
Results
Pressure Profiles
The line pressures were measured while the infusions were conducted within the MR imaging magnet. Pressure was compared with time, as shown in Fig. 1 , for trials of infusion in 0.6% agarose gel, 0.8% agarose gel, and pig brain; the initial transients reached mean peak values of approximately 32, 108, and 52 mm Hg, respectively. The error bars represent one SD. After attaining the peak value, the pressure rapidly decreased to a relatively stable plateau, and stayed at or near that level for the remainder of the experiment. The plateau pressure value of 0.6% agarose gel was typically close to that found in the pig brain tissue (10-20 mm Hg).
Volumes of Distribution
The time course of expansion of the volume of distribution for an infusion into the pig brain is shown in Fig. 2 , and that for an infusion into the 0.6% agarose gel is shown in Fig. 3 . The infusions were conducted in the same fashion for both the gel and pig brain (see Materials and Methods). A full set of images of the brain or gel was acquired every 15 minutes. The images shown represent slices that were obtained through the midline of the infusion mass from each time interval. The first image was obtained at Time 0; subsequent images (second-ninth) represent the 2 hours of the infusion process, and the final four images represent the hour following cessation of the infusion.
Volumes of distribution are plotted as functions of the volume of infusion in Fig. 4 for both 0.6% agarose gel and pig brain, as measured by MR imaging. The error bars represent the SD for each time point for a set of three infusions in each case. The Pearson correlation coefficients for linear fits to the data are close to unity, with the slope of the agarose infusions approximately 28% steeper than that for infusions into the pig brain.
The 0.6% agarose gel is sufficiently transparent to permit videomicroscopic determination 7 of the volume of distribution. Figure 5 demonstrates the expanding volume of distribution of BPB dye in the gel at approximately 30-minute intervals. Combining these techniques allowed for a direct comparison of the volume of distribution as measured by MR imaging with that observed photooptically. A gel was prepared and infused with a mixture of BPB dye (MW 690) and the gadodiamide agent (MW 573). Expansion of the gadodiamide volume of distribution was monitored by MR imaging at 30-minute intervals for the 2 hours of infusion, and for 1 hour following cessation of the infusion. At this time (180 minutes), the gel was removed and videomicroscopic imaging and measurement of the BPB volume of distribution were conducted. The resulting data were compared with those of a similar infusion conducted in the pig brain in a parallel experiment. The results are shown in Fig.  6 . Note the nearly exact agreement between the values of the volumes of distribution for gadodiamide and BPB, as well as the similar values for the gadodiamide volume of distribution in the pig brain.
Penetration Forces
The motor-driven force gauge apparatus was used to determine the penetration transient and integrated tissue drag force acting on a 3-mm ventricular shunt catheter that moved through tissues and gel at a constant speed of 0. 
Discussion
Performance Characteristics and Limitations of the Gel Phantom
Analysis of data indicates that pressure profiles in the in vitro model depend on the gel concentration and that the lower-concentration gel (0.6%) more precisely replicates the plateau pressure found in the pig brain infusions (Fig. 1) . Observations made during many hundreds of gel infusions and in vivo infusions, namely, those described by Prabhu, et al., 24 have indicated that the pressure transient that appears at the beginning of the infusion is consistent with a valve effect associated with the elasticity of the material into which the catheter or cannula is inserted. The results reported by these authors were interpreted as ruling out the presence of a tissue plug within the bore of the cannula as an explanation of the observed transient pressures. Our use of real-time videomicroscopy to monitor the volume distribution has allowed us to observe displacement of the gel at the needle port at the time that distribution of BPB commences, with a subsequent decrease in the infusion pressure toward the plateau value. Furthermore, the use of a cannula with an infusion port on the side results in a smaller transient peak pressure, if any, whereas the plateau pressure attained is roughly the same (data not shown). Our conclusion is that the valve effect is more pronounced with an end-port catheter, although the resulting volume of distribution is not substantially different from that of a device with side ports.
Backflow of infusate along the catheter or cannula insertion track can occur for many reasons and has been studied in our laboratories 20 and by others. 6 As shown in the present study, careful placement of the primed delivery device within the brain or gel to depths of 2.5 cm or greater led to a radial distribution of dye free from backflow: there is no region of enhancement seen along the upper portion of the insertion paths shown in Figs. 2 and 3 , and no visible evidence of backtracking present in the videomicroscopic image in Fig. 6 . Hence, the gel also mimics the brain in its ability to create a seal against the outer wall of a delivery device that is inserted into it. Our studies have confirmed that careful advancement of the cannula into the gel or brain through a properly fitting stereotactic guide is critical for minimizing the backtracking of infusate along the cannula track (data not shown). In particular, manual placement of the cannula is invariably associated with significantly greater backtracking of infusate, sometimes with efflux of the infusate around the cannula implantation point. Presumably, this is due to the unavoidable lateral movements of the cannula during the free-hand insertion, which create a larger track around the cannula. This particular finding has important implications for neurosurgical implementation of CED, as well as the likelihood of success of clinical studies that involve direct injection of materials such as viral vectors, cells, and chemotherapeutic agents into the brain. The use of a stereotactic guide and a controlled-rate infusion system is thus highly recommended.
As shown in Fig. 4 , the 0.6% agarose gel exhibited a V d / V i ratio that was approximately 28% greater than that of the in vivo pig brain: 10 for the agarose gel compared with 7.1 for the pig brain. The plateau pressures in both cases were roughly the same at approximately 60 minutes or longer.
One possible interpretation of this finding is that the average flow resistance of the gel is less than that of the brain by roughly that amount-it has a hydraulic conductivity not quite a third higher than that of the brain. Also, as indicated by the symmetries in the volumes of distribution shown in Figs. 3 and 6 , the gel is more homogeneous and isotropic than the brain, as would be expected. Nevertheless, there is a roughly cylindrical symmetry in the volumes of distribution in the pig brain shown in Fig. 2 . In any case, the agreement between the V d /V i ratios for the gel and brain is adequate to warrant use of the gel in a variety of infusion testing protocols commonly used to evaluate the characteristics of catheter performance. Indeed, the expected symmetry of distribution offered by the gel system will allow some advantages in catheter testing because any anomalies in the distribution of infusate can be attributed to the catheter configuration without the confounding effect of the brain's anisotropy.
In general, the flow characteristics of the infusion process will be a function of the properties of the infusate (namely, solute particle size and charge) and of the material into which it is delivered (namely, the degree of axonal alignment). We have adhered to this perspective in all our CED investigations, both in vivo and in vitro, over the past decade. Although the present study focuses on the similarities
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Brain phantom for infusion studies of the results obtained in the gel phantom material and in the porcine brain, it is only one part of the larger effort in our laboratories aimed at investigating CED flows of several different agents in a variety of clinically relevant in vivo and in vitro models. Table 1 summarizes the results of a number of those studies. We include the present study in this table as well as pertinent experiments now in progress.
The use of MR imaging to monitor the spread of the infusate even in the postinfusion period was validated by the correspondence between the volume of distribution as measured by MR imaging and that obtained by videomicroscopy, as shown in Fig. 6 . The inverse of this point is that videomicroscopy of infusions of dyes into gels serves as a useful model for the more clinically realistic situation in which the progress of an intraparenchymal infusion would be tracked by an appropriate form of MR imaging. Similar validations of an MR imaging-based measurement of tumor volumes, compared with those derived from Evans blue dye infusions and histological analyses, have also been made in our laboratories, 25 as have direct measurements of volumes of infusate distribution via autoradiography. comparison with the measure taken at the comparable time point in agarose gel, the lower volume of distribution demonstrated in the pig brain 1 hour after cessation of the infusion may, in contrast to the static in vitro gel model, reflect the effects of clearance processes in the perfused and viable brain. Such differences offer the potential for analyzing the contribution of the clearance processes directly and might allow for more accurate modeling and prediction of infusate distribution for the purpose of treatment planning. Similar questions arise regarding the attenuation in plateau pressure observed at the end of an infusion in gel compared with the relative stability of postinfusion pressures measured in porcine brain (see Fig. 1 ). The metabolic activity present in the latter undoubtedly contributes to this difference, although we have not yet developed a suitable hypothesis for further testing. Finally there is the issue of diffusion of the infusate many hours postinfusion (namely, 24-72 hours). Although diffusive flow along a concentration gradient is a much slower process than CED, it does contribute to the volume of distribution and many studies of it have been undertaken. 21 The present study was not designed to evaluate the long-term effects of diffusion on the postinfusion volumes of distribution, but we have explored this point and shown in other studies 3 how the volume of distribution varies over long times.
The macroscopic characteristics of the gel replicate those of the brain in the material's response to the insertion of surgical probes. The values of the penetration transient are similar for agarose gel and brain in these studies, and the drag forces associated with further advancement of the catheter into gel and brain are almost identical. Moreover, the values of the penetration transient and those of the cumulative drag force acting on the inserted catheter are within 5 to 10% of those found previously in living human brain tissue. 14 Although a significant advantage of the present form of the agarose model is its simplicity, it lacks several of the critical attributes of in vivo models of infusion. Most notably, it is inert and unperfused, and thus is not useful for evaluating the uptake and clearance of infused agents. Also, it is a largely homogeneous and isotropic material, whereas brain tissues are inhomogeneous and highly anisotropic (especially in regions of white matter where fiber tracts have clear directionality). This is expected to limit the ability of the gel to replicate fully the complex flow patterns that occur in the brain. Indeed, we believe one of the values of the agarose gel model is to serve as a much simplified version of the human brain, in which fundamental aspects of the behavior of infusion catheters and infusates can be studied as an complex in vivo situation. We have made some preliminary efforts at developing inhomogeneous gel models of infusion into brain plus tumor 26 and into spinal cord, 11 but that work is not yet at the level at which it can be used to test and/ or validate mathematical descriptions of the flow of an infusate through a porous compound gel medium. Nevertheless, because of the widespread interest in using gels as brain tissue phantoms for sophisticated tests of neuroimaging devices and radiotherapy protocols, there are examples on which one can draw for expanding the gel model's overall degree of complexity, if that should prove a useful path to follow. For example, various researchers have simulated anthropomorphic features by using gels, 5 investigated MR imaging-based dosimetry of radiotherapies delivered to gels, 9 established stereotactic localization limits in anisotropic gelatin phantoms, 22 and otherwise explored this general approach for neurosurgical and other medical applications. 16, 19, 23 It is also interesting that the similar V d /V i ratios for agarose gel and brain mean that the "exclusion volumes" for the two materials are similar. In the case of brain, the exclusion volume has traditionally been taken as the intracellular space, whereas in the case of agarose gel, this must comprise the dissolved complex polysaccharides from the dry agarose. The dry volume of this material, however, is much smaller than the implied volume deriving from the exclu- sion volume. Thus, agarose polysaccharides are presumably associated with a substantial volume of hydration, which is not accessible to a low-MW hydrophilic dye (BPB). A full understanding of how gel's similarity to brain in its response to the CED of an infusate calls requires direct measurements of the interstitial pore size of the gel and a comparison of that with the extracellular space. Work is now in progress by Gillies and coworkers 10 to address this need.
Future Studies
Validation of the 0.6% agarose gel as a reasonable facsimile of the brain allows planning of more long-term studies of infusion to mimic the expected duration of actual therapeutic interventions in patients. Thus, infusions lasting longer than 24 hours now need to be studied in the gel model to characterize the behavior of infusate distribution, infusion pressure parameters, and infusion catheter performance under these more realistic longer-scale conditions. In particular, studies of catheter design for long-term and multisite infusions are planned to model the delivery of therapeutic macromolecular agents to focal and/or wide regions of the brain. Similar studies designed to investigate effects on the volumes of distribution and pressure profiles of infusions with and without columns of entrapped air inside the catheter are also being performed, and work is underway to expand the gel model to serve as a possible surrogate for spinal cord infusion studies.
11
Conclusions
Low-concentration agarose gels serve as a useful surrogate for in vivo brain tissues in testing different protocols for positive pressure infusion of therapeutic agents into the central nervous system. The pressure profiles and volumes of distribution of low-molecular-weight dyes and imaging contrast agents infused into a 0.6% agarose gel and an in vivo porcine model are strikingly similar and validate the use of the gel as a test bed for CED strategies and studies of the performance characteristics of a variety of intraparenchymal drug delivery devices.
